Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Net Income: 2010-2025

Historic Net Income for Ligand Pharmaceuticals (LGND) over the last 16 years, with Sep 2025 value amounting to $117.3 million.

  • Ligand Pharmaceuticals' Net Income rose 1735.15% to $117.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year increase of 7.38%. This contributed to the annual value of -$4.0 million for FY2024, which is 142.16% down from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Net Income of $117.3 million as of Q3 2025, which was up 2,319.50% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, Ligand Pharmaceuticals' Net Income peaked at $117.3 million during Q3 2025, and registered a low of -$51.9 million during Q2 2024.
  • Moreover, its 3-year median value for Net Income was -$1.7 million (2023), whereas its average is $7.7 million.
  • Examining YoY changes over the last 5 years, Ligand Pharmaceuticals' Net Income showed a top increase of 5,273.51% in 2024 and a maximum decrease of 2,366.86% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Net Income (Quarterly) stood at -$2.2 million in 2021, then crashed by 32.75% to -$3.0 million in 2022, then skyrocketed by 716.33% to $18.2 million in 2023, then slumped by 270.93% to -$31.1 million in 2024, then spiked by 1,735.15% to $117.3 million in 2025.
  • Its Net Income was $117.3 million in Q3 2025, compared to $4.8 million in Q2 2025 and -$42.5 million in Q1 2025.